For 2023, Boston Scientific is also targeting 50bps annual margin expansion and "strong" free cash flow. Comments made by CEO Michael Mahoney at the JPMorgan Healthcare Conference.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on BSX: